Paxlovid does not lower risk of long-term COVID-19 symptoms, UCSF study shows

Paxlovid doesn’t reduce risk of long COVID, UCSF study finds

Paxlovid does not lower risk of long-term COVID-19 symptoms, UCSF study shows

In a new study from UCSF, researchers found that patients who took Paxlovid and those who did not had similar outcomes when it came to long COVID symptoms.

Paxlovid does not lower risk of long-term COVID-19 symptoms, UCSF study shows

In a new study from UCSF, researchers found that patients who took Paxlovid and those who did not had similar outcomes when it came to long COVID symptoms.

Paxlovid does not lower risk of long-term COVID-19 symptoms, UCSF study shows

In a new study from UCSF, researchers found that patients who took Paxlovid and those who did not had similar outcomes when it came to long COVID symptoms.

Paxlovid does not lower risk of long-term COVID-19 symptoms, UCSF study shows

In a new study from UCSF, researchers found that patients who took Paxlovid and those who did not had similar outcomes when it came to long COVID symptoms.

Paxlovid does not lower risk of long-term COVID-19 symptoms, UCSF study shows

In a new study from UCSF, researchers found that patients who took Paxlovid and those who did not had similar outcomes when it came to long COVID symptoms.